Delivery Order SPE2DB24D8003-SPE2DB25FJUJS
Award Date
5/9/25
Potential Completion Date
5/12/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,042.84, is for the delivery of 4,567,372,214 lisdexamfetamine 40 mg capsules, to be completed by February 26, 2025. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The award, with a contract number of SPE2DB24D8002|SPE2DB25FJNDD, is for the delivery of 4,567,235 units of 50 mg lisdexamfetamine capsules. The contract has a firm fixed-price delivery order type with a ceiling value of $1,350.58 and a completion date of February 12, 2025. Dakota Drug, Inc. is also the holder of a significant single-award Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,000.64, is for the delivery of 4566862011 - LISDEXAMFETAMINE 40 MG CAPSULE 100S to support U.S. Armed Forces medical operations. The contract has a firm fixed price pricing type and an ultimate completion date of January 8, 2025. It is not a set-aside contract. Dakota Drug, Inc. is a key supplier for the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $6,027.24 firm fixed price contract is for the delivery of 4,563,197,924 units of Methylphenidate ER 27 mg tablets in 100 count packages. This contract has an ultimate completion date of December 29, 2023. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the DLA...
This is a $1,979.66 firm fixed-price delivery order awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract is for the delivery of 4562235206 VYVANSE 50 MG CAPSULE 100S, a pharmaceutical product. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. The IDC is part of the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 4,567,720,329 units of Methylphenidate ER 27 mg tablets in 100-count bottles. The $6,259.23 contract has a performance period ending on March 28, 2025. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the agency's ECAT Generation V Program, which allows the company to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,611.66, is for the delivery of dextroamphetamine-amphetamine 10 mg tablets. The contract has a firm fixed price and is set to expire on June 20, 2024. Dakota Drug, Inc. also holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop...
This is a federal contract award by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,254.00 firm fixed-price delivery order is for the supply of 4,566,177,751 units of Dexmethylphenidate ER 5 mg capsules. The award is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, under the DLA Troop Support Medical's ECAT Generation V Program. This IDC allows the company to provide a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,455.96, is for the delivery of 4,568,086,095 units of Lisdexamfetamine 10 mg capsules. The contract is a firm fixed-price, non-set-aside award with a period of performance through May 1, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
The Defense Logistics Agency (DLA) awarded a $5,476.61 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 4,565,321,317 units of Methylphenidate ER 18 mg tablets. This order falls under Dakota Drug, Inc.'s existing Indefinite Delivery Contract (IDC) SPE2DB24D8001, valued at $999,999,999.00, which allows the company to provide a wide range of pharmaceutical products, medical supplies, and healthcare equipment to...